Molecular Diagnostics
Total Trials
25
As Lead Sponsor
6
As Collaborator
19
Total Enrollment
10,875
NCT01198262
Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections
Phase: N/A
Role: Collaborator
Start: Apr 30, 2008
Completion: Aug 31, 2010
NCT01813500
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Start: Oct 31, 2011
Completion: Apr 30, 2016
NCT01587469
Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects
Role: Lead Sponsor
Start: May 31, 2012
Completion: Feb 21, 2014
NCT01989130
Evaluation of Immediate v. Delayed CT/NG Test for Treatment in the ED
Start: Oct 31, 2013
Completion: Mar 31, 2015
NCT02461576
Clinical Evaluation of the Xpert® HIV-1 VL
Start: Jul 31, 2015
Completion: Feb 24, 2017
NCT02386514
Emergency Department, Rapid Assessment for Sexually Transmitted Infection
Start: Jun 30, 2016
Completion: Jun 30, 2016
NCT02895620
Effect on Xpert® Bladder Test of Urines Inflammatory Milieu Induced by BCG Treatment of Patients With NMIBC
Start: Aug 31, 2016
Completion: Aug 31, 2017
NCT02922816
FMT for MDRO Colonization After Infection in Renal Transplant Recipients
Phase: Phase 1
Start: Dec 1, 2016
Completion: Dec 3, 2021
NCT03125460
Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer
Start: Dec 31, 2016
Completion: May 31, 2019
NCT02755402
Accelerated Pre-treatment Evaluation for HCV Infected Persons Who Inject Drugs
Start: Jan 31, 2017
Completion: May 31, 2021
NCT03421626
Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML)
Start: Nov 8, 2017
Completion: Aug 20, 2018
NCT03715660
Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study
Start: Mar 1, 2018
Completion: Oct 1, 2019
NCT03664258
A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)
Start: Jun 6, 2018
Completion: Jan 31, 2022
NCT03734172
Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB)
Start: Jan 21, 2019
Completion: Dec 31, 2022
NCT04647981
Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test.
Start: May 22, 2019
Completion: Jan 2, 2021
NCT03936816
The Implementation of Real-time PCR - Intrapartum GBS (Group B Streptococcus) Colonization to Reduce Antibiotic Prophylaxis
Start: Jun 1, 2019
Completion: Aug 30, 2020
NCT03728725
Xpert MTB/XDR Clinical Evaluation Trial
Start: Jul 11, 2019
Completion: Aug 18, 2020
NCT04100733
Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor
Start: Nov 1, 2019
Completion: Apr 30, 2027
NCT04610762
HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels
Start: Nov 17, 2020
Completion: Nov 17, 2022
NCT04793750
Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC)
Start: Aug 18, 2021
Completion: Mar 31, 2025
NCT04878328
Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO
Start: Apr 14, 2022
Completion: May 22, 2025
NCT06281691
GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit
Start: Apr 28, 2023
Completion: Nov 30, 2025
NCT06508996
Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System
Start: Feb 6, 2024
Completion: Jun 6, 2024
NCT06438575
Point of Care Diagnosis of Vaginal Infections
Start: Jun 16, 2024
Completion: Mar 26, 2025
NCT03767231
ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing
Start: Nov 30, 2025
Completion: Nov 30, 2027
Loading map...